Suppression by cyclohexanetriones of retinoic acid-induced cartilage degradation in vitro and teratogenicity in vivo.
In cultured fetal rat bones, cyclohexanetriones that stimulate prostaglandin synthesis inhibited retinoic acid-induced cartilage degradation in a dose-dependent manner. The inhibition by the cyclohexanetrione Ro 31-0521 was reversible, indicating that the effect was not due to cytotoxicity. Excess retinoic acid is teratogenic in rats and adversely affects the normal differentiation of various morphogenetic systems, depending on the time of administration. The following retinoic acid-induced malformations were suppressed by Ro 31-0521: malformations of long bones and of apical phalanges induced on days 13 and 15 of gestation, respectively; spina bifida and tail malformations induced on day 11 of gestation and cleft palate induced on day 15 of gestation. However, cleft palate and other head malformations including exencephaly induced by retinoic acid on day 11 of gestation were not suppressed but even increased by Ro 31-0521. At a high dose, Ro 31-0521 given alone on day 11 of gestation was embryolethal and teratogenic but was not on the tested other days, indicating that the cyclohexanetrione at specific stages and doses also interfered with normal morphogenesis like retinoic acid. Assuming that stimulation of prostaglandin synthesis is the main biological effect of the cyclohexanetriones, our findings suggest that prostaglandins may be involved in mediating retinoid action.
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000818:Animals; D001862:Bone Resorption / Q000187:drug effects; D002356:Cartilage / Q000187:drug effects* / Q000378:metabolism; D002972:Cleft Palate / Q000139:chemically induced; D003510:Cyclohexanes / Q000494:pharmacology*; D003512:Cyclohexanones / Q000494:pharmacology*; D005865:Gestational Age; D017880:Limb Deformities, Congenital; D008297:Male; D009924:Organ Culture Techniques; D011453:Prostaglandins / Q000096:biosynthesis*; D011509:Proteoglycans / Q000378:metabolism; D051381:Rats; D012098:Reproduction / Q000187:drug effects; D014212:Tretinoin / Q000037:antagonists & inhibitors*
D003510:Cyclohexanes; D003512:Cyclohexanones; D011453:Prostaglandins; D011509:Proteoglycans; C047848:Ro 31-0521; D014212:Tretinoin